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Abstract
Introduction:  Mooren's ulcer is a rare disorder of unknown etiology that is refractory to
treatment. It can affect not just the cornea but also the scleral tissue and can involve both eyes.
Case presentation: We report a case of a 74-year-old man with a history of bilateral and
malignant Mooren's ulcer. The patient had undergone an exenteratio bulbi of the left eye because
of the perforation of a Mooren's corneal ulcer. The perforated Mooren's corneal ulcer also
presented in the right eye and involved the adjacent scleral tissue. It was decided to perform a
corneal-scleral graft to preserve the anatomical integrity of the eye.
Conclusion: This report highlights how a corneal-scleral graft followed by systemic and local
immunosuppressive treatment should be considered in monocular patients with malignant
Mooren's ulcer where there is serious damage to the corneal and scleral tissue.
Introduction
Mooren's ulcer is a rare disorder involving the chronic and
painful ulceration of the cornea. The lesion with over-
hanging edges generally starts on the periphery and tends
to spread progressively to the entire circumference or
towards the centre of the cornea. As well as the cornea, the
sclera can also be involved with an incidence of 13.5% of
eye perforation and loss of vision [1]. When not only the
cornea but also the sclera is involved in eye perforation it
can be necessary to perform a large corneoscleral graft to
save the eye. We describe a case of anterior segment recon-
struction using corneoscleral grafts of 14 mm in diameter
in a patient with Mooren's ulcer and eye perforation.
Case presentation
A 74-year-old male presented at our clinic with a 10-day
history of mild pain and loss of vision in his right eye. In
2003, he had undergone an exenteratio bulbi with the
insertion of a prosthesis in the left eye following the cor-
neal perforation of a Mooren's ulcer. Medical examination
revealed acute conjunctival hyperaemia and a large perfo-
rated Mooren's ulcer in the right eye. The anterior cham-
ber was absent and a seclusio pupillae with cataract were
also present (Figure 1). Visual acuity was hand move-
ments. Under general anaesthesia, we performed a 14 mm
corneoscleral transplantation in association with the ext-
racapsular extraction of the cataract, intraocular lens
implantation and superior basal iridectomy.
The surgical technique included a total limbal peritomy in
attempt to save limbal stem cells. A 14 mm trephine was
used to mark and partially cut the scleral surface. After
careful haemostasis, the anterior chamber was entered
obliquely with a diamond knife and the sclera was cut
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with Castroviejo's corneal scissors. The entire cornea and
scleral ring was removed, viscoelastic material was placed
on the recipient bed and a large anterior capsulorhexis
was performed. After the expression of the lens nucleus
and aspiration of residual masses, an intraocular lens was
implanted into the capsular bag and a peripheral iridec-
tomy was performed. The donor tissue was trephined
from a whole eye used within 24 hours of the donor's
death and stored in a moist chamber using a trephine of
the same diameter as that used on the recipient. The
donor corneoscleral graft was then sutured into place onto
the scleral ledge using 8.0 interrupted silk sutures. The
anterior chamber was filled with viscoelastic material and
the conjunctiva was closed with Vicryl 8.0 interrupted
sutures.
The day after surgery we found a mild keratitis with a low
flare in the anterior chamber. The intraocular pressure
measured with a pneumotonomer was 14 mm/Hg. Post-
operative steroid therapy was prednisolone acetate 1%
every two hours for four weeks (decreased to four times a
day for five months), oral cyclosporine A (5 mg/kg/day)
for six months and prednisone 25 mg a day for four
months. After six months, the best corrected visual acuity
was 6/60 (Figure 2).
Conclusion
The presented case was a malignant form of bilateral
Mooren's ulcer that had already caused a corneal perfora-
tion in the left eye with consequent phthisis bulbi. Local
and systemic treatment with cortisone failed to prevent
the progression of the disorder and perforation of the
right eye and, therefore, a corneoscleral graft was neces-
sary.
The etiopathogenesis of Mooren's ulcer is still unknown.
It is probably an autoimmune disease. Indeed, anti-cor-
neal and anti-conjunctival tissue antibodies have been
isolated from patients suffering from this disorder [2].
Furthermore, the conjunctival tissue surrounding the
lesion is generally rich in proteo-glycolytic enzymes
secreted by mononucleate cells and neutrophils that pro-
gressively infiltrate the area surrounding the ulcer [3].
Another confirmation of the autoimmune origin of the
disorder is the T-suppressor lymphocytes deficit in patient
blood samples [4].
Wood and Kaufman classified Mooren's ulcer in two main
forms [5]. Type 1 is the benign form, generally monola-
teral, which mainly affects the elderly. The symptoms are
unclear but this type responds well to medical treatment
and surgery. Type 2 is the malignant form. It can occur
bilaterally in 25% of cases in white subjects and 75% in
black subjects. It mainly affects the young. Watson
divided the disease into three types based on the clinical
presentation: unilateral Mooren's ulcer, bilateral aggres-
sive Mooren's ulcer and bilateral indolent Mooren's ulcer
[6].
In the third type of Watson and in the malignant form, we
have a slowly progressive ulcer that affects not just the cor-
nea but also the scleral tissue. For this reason, neither con-
ventional medical nor surgical treatment is sufficient, and
it can be necessary to perform a large corneal graft to pre-
serve the anatomical integrity of the eye.
Perforated Mooren's ulcer Figure 1
Perforated Mooren's ulcer.
Corneoscleral graft after six months Figure 2
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Indeed, it is extremely difficult to treat Mooren's ulcer and
in many cases, the results are poor. Treatment starts with
cortisone administered systemically and locally, but if this
is unsuccessful, the complete excision of the perilimbal
conjunctiva and episclera near the ulcer is made [6]. The
use of immunosuppressive drugs, in particular
cyclosporin A, should be reserved for more severe forms
[7]. In the event of ulcer perforation, the area can be cov-
ered with amniotic membrane or a lamellar keratoplasty
can be performed [8]. In this case, because of the presence
of a large, perforated corneal ulcer affecting the scleral tis-
sue, it was decided to perform a corneoscleral graft.
The use of this type of surgery to treat serious corneal dis-
orders was first proposed in the early 1970s [9]. The per-
centage of surviving graft tissue has always been very low
mainly because of the early onset of epithelial damage to
the transplanted tissue, recurrence of the underlying dis-
order or secondary glaucoma caused by the disturbance of
the iridocorneal angle and thereby of aqueous humour fil-
tering [10].
In this case, the particular technique used made it possible
to preserve the iridocorneal angle, and the administration
of systemic and local cyclosporin treatment avoided the
onset of secondary glaucoma as well as any sign of rejec-
tion six months after the operation. For this reason, we
think that this type of graft can be proposed mainly for
monocular patients with malignant Mooren's ulcer where
there is serious damage to the corneal and scleral tissue
and where eyes would otherwise be condemned to a com-
plete loss of vision.
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